Engineers Gate Manager LP Mannkind Corp Transaction History

Engineers Gate Manager LP

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$3.91 - $5.45 $29,927 - $41,714	-7,654 Reduced 17.81%	35,318 $145,000
Q2 2023 Aug 14, 2023	BUY	$3.72 - $4.79 $96,232 - $123,912	25,869 Added 151.25%	42,972 $174,000
Q1 2023 May 15, 2023	BUY	$3.95 - $5.63 $67,556 - $96,289	17,103 New	17,103 $70,000
Q2 2022 Aug 15, 2022	SELL	$2.67 - $4.77 $64,595 - $115,400	-24,193 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$2.62 - $4.45 $63,385 - $107,658	24,193 New	24,193 $89,000
Q4 2021 Feb 14, 2022	SELL	$4.05 - $5.37 $47,798 - $63,376	-11,802 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$3.89 - $5.48 $421,726 - $594,103	-108,413 Reduced 90.18%	11,802 $51,000
Q2 2021 Aug 16, 2021	BUY	$3.61 - $5.45 $389,934 - $588,681	108,015 Added 885.37%	120,215 $655,000
Q1 2021 May 17, 2021	BUY	$3.14 - $6.14 $38,308 - $74,908	12,200 New	12,200 $48,000
Q3 2020 Nov 16, 2020	SELL	$1.56 - $2.08 $19,032 - $25,376	-12,200 Closed	0 $0
Q2 2020 Aug 17, 2020	BUY	$0.94 - $2.21 $11,468 - $26,962	12,200 New	12,200 $21,000
Q2 2019 Aug 14, 2019	SELL	$1.09 - $1.88 $12,054 - $20,790	-11,059 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$1.14 - $2.25 $12,607 - $24,882	11,059 New	11,059 $22,000

244

148M

1.62M

802K

Ticker MNKD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 257,338,000
Market Cap $1.57B
Description
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

Stay updated on Engineers Gate Manager LP with notifications on news.